Ticker: CO, Company: China Cord Blood Corp, Type: 20-F, Date: 2013-07-31, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CO/20130731/20-F_1/1/000.htm SEC Original: v349858_20f.htm
TABLE OF CONTENTS PART I 4 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 4 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 4 ITEM 3. KEY INFORMATION 4 A. Selected financial data 4 B. Capitalization and Indebtedness 6 C. Reasons for the Offer and Use of Proceeds 7 D. Risk factors 7 ITEM 4. INFORMATION ON THE COMPANY 36

---

---

Webplus: CO/20130731/20-F_1/2_EX-4.24/000.htm SEC Original: v349858_ex4-24.htm
Guangzhou City Real Estate Property Purchase Agreement Seller (Party A): Guangzhou Hezhong CD Manufacturing Co., Ltd. Legal Representative: ZHU Suifeng Buyer (Party B): Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. Legal Representative: ZHENG Ting Article I Party A desires to transfer the real estate property it owns, including the land use right to the surrounding public green area and road

---

---

Webplus: CO/20130731/20-F_1/3_EX-4.25/000.htm SEC Original: v349858_ex4-25.htm
Hundsun (Hangzhou) Science & Technology Park Property Transfer Agreement Contract #: H216 ( Party A (Transferor): Hangzhou Hundsun Baichuan Technology Co., Ltd. Legal Representative: HU Weiguo Party B (Transferee): Beijing Jiachenhong Biological Technologies Co., Ltd. Legal Representative: DENG Yue Article I Background of the Construction Project Party A entered into an agreement “State Construction Land Use Right Transfer Contract” (contract

---

---

Webplus: CO/20130731/20-F_1/4_EX-8.1/000.htm SEC Original: v349858_ex8-1.htm
List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. People’s Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. People’s Republic of China Zhejiang Lukou Biotechnology Co., Ltd. People’s Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem

---

---

Webplus: CO/20130731/20-F_1/5_EX-12.1/000.htm SEC Original: v349858_ex12-1.htm
Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements

---

---

Webplus: CO/20130731/20-F_1/6_EX-12.2/000.htm SEC Original: v349858_ex12-2.htm
Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements

---

---

Webplus: CO/20130731/20-F_1/7_EX-13.1/000.htm SEC Original: v349858_ex13-1.htm
Certification CHINA CORD BLOOD CORPORATION July 31, 2013 Ting Zheng Chief Executive Officer July 31, 2013 Albert Chen Chief Financial Officer (Principal Financial and Accounting Officer)

---

---

Webplus: CO/20130731/20-F_1/8_EX-15.1/000.htm SEC Original: v349858_ex15-1.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The Board of Directors China Cord Blood Corporation: Hong Kong, China July 31, 2013

---

Company Information:

Ticker: CO, Company: China Cord Blood Corp, Type: 20-F, Date: 2013-07-31, XBRL Interactive FinancialsCIK: 0001467808, Location: K3, SIC: 6770, SIC Desc: BLANK CHECKS
Business Phone & Address:
48 FL., BANK OF CHINA TOWER, 1 GARDEN ROAD
CENTRAL HONG KONG, K3 000000